Palliative care from the beginning of treatment for advanced pancreatic cancer

Journal of the Pancreas

Volumn 11, Issue 2, 2010, Pages 154-157

  Lazenby, James Mark ^a   Saif, Muhammad Wasif ^b  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

Palliative care; Pancreatic neoplasms

Indexed keywords

ACETIC ACID DERIVATIVE; ANTICOAGULANT AGENT; MEGASTEROL ACETATE; OLANZAPINE; THALIDOMIDE; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANOREXIA; ANTICOAGULANT THERAPY; BODY WEIGHT; CACHEXIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; MEDICAL RECORD REVIEW; MUSCLE MASS; PANCREAS CANCER; PREDICTION; QUALITY OF LIFE; RETROSPECTIVE STUDY; VEIN THROMBOSIS; WEIGHT REDUCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CONGRESSES AS TOPIC; DISEASE PROGRESSION; GASTROINTESTINAL NEOPLASMS; HUMANS; PALLIATIVE CARE; PANCREATIC NEOPLASMS; TIME FACTORS;

EID: 77749245780     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al (eds). SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975-2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009.
2. Lau MK, Davila JA, Shaib YH. Incidence and Survival of Pancreatic Head and Body and Tail Cancers: A Population-Based Study in the United States. Pancreas 2009 Nov 16. [PMID 19924019]
3. Hackert T, Büchler MW, Werner J. Surgical options in the management of pancreatic cancer. Minerva Chir 2009; 64:465-476. [PMID 19859037]
4. House MG, Choti MA. Palliative therapy for pancreatic/biliary cancer. Surg Oncol Clin N Am 2004; 13:491-503. [PMID 15236731]
5. Sohn TA, Lillemoe KD, Cameron JL, Huang JJ, Pitt HA, Yeo CJ. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg 1999; 188:658-666. [PMID 10359359]
6. World Health Organization. Cancer: Palliative care. WHO Programmes and Projects.
7. Labori KJ, Hjermstad MJ, Wester T, Buanes T, Loge JH. Symptom profiles and palliative care in advanced pancreatic cancer-a prospective study. Support Care Cancer 2006; 14:1126-33. [PMID 16601947]
8. Uomo G, Gallucci F, Rabitti PG. Anorexia-cachexia syndrome in pancreatic cancer: recent development in research and management. JOP. J Pancreas (Online) 2006; 7:157-62. [PMID 16525199]
9. Crippa S, Domínguez I, Rodríguez JR, Razo O, Thayer SP, Ryan DP, et al. Quality of life in pancreatic cancer: analysis by stage and treatment. J Gastrointest Surg 2008; 12:783-94. [PMID 18317851]
10. Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations - a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 2005; 23:6240-8. [PMID 16135490]
11. Nieveen van Dijkum EJ, Kuhlmann KF, Terwee CB, Obertop H, de Haes JC, Gouma DJ. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 2005; 92:471-7. [PMID 15672431]
12. Freitas D, Dos Santos Fernandes G, Hoff P, Cunha, JE. Medical management of pancreatic adenocarcinoma. Pancreatology 2009; 9:223-32. [PMID 194209891]
13. Mortenson MM, HO HS, Bold RJ. An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer. Am J Surg 2005; 190:406-11. [PMID 16105527]
14. Artifon EL, Sakai P, Cunha JE, Dupont A, Filho FM, Hondo FY, et al. Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer. Am J Gastroenterol 2006; 101:735-42. [PMID 16968509]
15. Ellis CM, Shenoy S, Litwin A, Soehnlein S, Gibbs JF. Effective endovascular stenting of malignant portal vein obstruction in pancreatic cancer. HPB Surg 2009; 2009:426-36. [PMID 19826629]
16. Yamakado K, Nakatsuka A, Tanaka N, Fujii A, Terada N, Takeda K. Malignant portal venous obstructions treated by stent placement: significant factors affecting patency. J Vasc Interv Radiol 2001; 12:1407-15. [PMID 11742015]
17. Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 2009; 27:5513-8. [PMID 19858379]
18. Yip D, Karapetis C, Strickland A, Steer CB, Goldstein D. WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev 2009; 3:CD002093. [PMID 19821291]
19. Gupta D, Rodeghier M, Grutsch JF, Lis CG. Predicting survival in advanced pancreatic cancer: The role of symptom clusters. 2010 ASCO Gastrointestinal Cancers Symposium. Abstract No. 265.
20. Price LH, Nguyen MB, Picozzi VJ, Kozarek RA. Portal vein thrombosis in pancreatic cancer: Natural history, risk factors, and implications for patient management. 2010 ASCO Gastrointestinal Cancers Symposium. Abstract No. 143.
21. Sanchetee SC. Thalidomide versus thalidomide with olanziapine and megastrol acetate in treatment of cachexia in gastrointestinal cancer: A randomized trial. 2010 ASCO Gastrointestinal Cancers Symposium. Abstract No. 209.
22. Subbiah S, Aldoss I, Gonsalves W, Tashi T, Al-Howaidi I, Silberstein PT. Adjuvant chemotherapy versus chemoradiation therapy in resectable pancreatic cancer: Retrospective analysis from the VA Central Cancer Registry (VACCR) database. 2010 ASCO Gastrointestinal Cancers Symposium. Abstract No. 230.
23. Aldoss I, Subbiah S, Gonsalves W, Fang X, Silberstein PT. Benefit of chemotherapy in very elderly patients (≥ 80) with metastatic pancreatic cancer: VA Central Cancer Registry (VACCR) database analysis. 2010 ASCO Gastrointestinal Cancers Symposium. Abstract No. 232.